Toshihiko Kobayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toshihiko Kobayashi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Noriko Toyama-Sorimachi
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4 shared publications Shiho Shimabukuro-Demoto
Department of Molecular Immunology and Inflammation, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
3 shared publicationsHitomi Karyu
Department of Molecular Immunology and Inflammation, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
2 shared publicationsNorihiro Kato
Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
2 shared publicationsTadashi Okamura
Department of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan
2 shared publicationsTsubasa Tanaka
2 shared publications
Latest Publications
- 12 August 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (33)
SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress
Significance: SLC15A4 is a lysosome-resident amino acid/oligopeptide transporter that is preferentially expressed in immune cells. SLC15A4 is required for TLR7/9-dependent type I interferon production and plays a critical role in the pathogenesis of lupus and colitis. However, the precise molecular mechanisms of SLC15A4-mediated inflammatory responses are still undetermined. We revealed that SLC15A4 loss disturbed the coupling of glycolysis and the TCA cycle, and SLC15A4-deficient macrophages preferred to use glutamine rather than glucose as a carbon source for the TCA cycle. SLC15A4-deficient macrophages produced low levels of itaconate and proinflammatory IL-12 cytokine members. Our results reveal a mechanism of metabolic regulation in which an amino acid transporter acts as a guardian to allow macrophages to acquire an M1-prone metabolic phenotype.
- 12 August 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (33)
SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress
Significance: SLC15A4 is a lysosome-resident amino acid/oligopeptide transporter that is preferentially expressed in immune cells. SLC15A4 is required for TLR7/9-dependent type I interferon production and plays a critical role in the pathogenesis of lupus and colitis. However, the precise molecular mechanisms of SLC15A4-mediated inflammatory responses are still undetermined. We revealed that SLC15A4 loss disturbed the coupling of glycolysis and the TCA cycle, and SLC15A4-deficient macrophages preferred to use glutamine rather than glucose as a carbon source for the TCA cycle. SLC15A4-deficient macrophages produced low levels of itaconate and proinflammatory IL-12 cytokine members. Our results reveal a mechanism of metabolic regulation in which an amino acid transporter acts as a guardian to allow macrophages to acquire an M1-prone metabolic phenotype.
- Open Access
- 15 November 2019
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 17 (11) , e3000530
Type I interferon limits mast cell–mediated anaphylaxis by controlling secretory granule homeostasis
Type I interferon (IFN-I) is a family of multifunctional cytokines that modulate the innate and adaptive immunity and are used to treat mastocytosis. Although IFN-I is known to suppress mast cell function, including histamine release, the mechanisms behind its effects on mast cells have been poorly understood. We here investigated IFN-I’s action on mast cells using interferon-α/β receptor subunit 1 (Ifnar1)-deficient mice, which lack a functional IFN-I receptor complex, and revealed that IFN-I in the steady state is critical for mast cell homeostasis, the disruption of which is centrally involved in systemic anaphylaxis. Ifnar1-deficient mice showed exacerbated systemic anaphylaxis after sensitization, which was associated with increased histamine in the circulation, even though the mast cell numbers and high affinity immunoglobulin E receptor (FcεRI) expression levels were similar between Ifnar1-deficient and wild-type (WT) mice. Ifnar1-deficient mast cells showed increased secretory granule synthesis and exocytosis, which probably involved the increased transcription of Tfeb. Signal transducer and activator of transcription 1(Stat1) and Stat2 were unexpectedly insufficient to mediate these IFN-I functions, and instead, Stat3 played a critical role in a redundant manner with Stat1. Our findings revealed a novel regulation mechanism of mast cell homeostasis, in which IFN-I controls lysosome-related organelle biogenesis.
- 15 November 2019
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 17 (11) , e3000530
Open AccessType I interferon limits mast cell–mediated anaphylaxis by controlling secretory granule homeostasis
Type I interferon (IFN-I) is a family of multifunctional cytokines that modulate the innate and adaptive immunity and are used to treat mastocytosis. Although IFN-I is known to suppress mast cell function, including histamine release, the mechanisms behind its effects on mast cells have been poorly understood. We here investigated IFN-I’s action on mast cells using interferon-α/β receptor subunit 1 (Ifnar1)-deficient mice, which lack a functional IFN-I receptor complex, and revealed that IFN-I in the steady state is critical for mast cell homeostasis, the disruption of which is centrally involved in systemic anaphylaxis. Ifnar1-deficient mice showed exacerbated systemic anaphylaxis after sensitization, which was associated with increased histamine in the circulation, even though the mast cell numbers and high affinity immunoglobulin E receptor (FcεRI) expression levels were similar between Ifnar1-deficient and wild-type (WT) mice. Ifnar1-deficient mast cells showed increased secretory granule synthesis and exocytosis, which probably involved the increased transcription of Tfeb. Signal transducer and activator of transcription 1(Stat1) and Stat2 were unexpectedly insufficient to mediate these IFN-I functions, and instead, Stat3 played a critical role in a redundant manner with Stat1. Our findings revealed a novel regulation mechanism of mast cell homeostasis, in which IFN-I controls lysosome-related organelle biogenesis.
- 1 January 2015
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 5 (16)
Separation of Intracellular Vesicles for Immunoassays
- 1 January 2015
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 5 (16)
Separation of Intracellular Vesicles for Immunoassays
- 1 December 2013
- Vol. 85 (12) , 1083-6
[The endosome-lysosome system in inflammatory signal transduction].
- 1 December 2013
- Vol. 85 (12) , 1083-6
[The endosome-lysosome system in inflammatory signal transduction].